Source: Wellteq
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Wellteq Digital Health (WTEQ) has signed an arrangement agreement with Advanced Human Imaging Ltd. (ASX: AHI)
  • Wellteq shareholders will receive one ordinary share of AHI for every six Wellteq common shares
  • AHI has agreed to advance up to A$1,200,000 to Wellteq
  • AHI is a provider of smartphone-based human scanning technology
  • Wellteq is a leading global provider of personalized digital health and wellness solutions
  • Wellteq Digital Health Inc (WTEQ) opened trading at C$0.02

Wellteq Digital Health (WTEQ) has signed an arrangement agreement with Advanced Human Imaging Ltd. (ASX:AHI).

Under the terms of the agreement, AHI will acquire all of the outstanding shares of Wellteq. Wellteq shareholders will receive one ordinary share of AHI for every six Wellteq common shares.

AHI will issue a total of approximately 17,811,508 shares for 100 per cent of Wellteq’s issued shares.

AHI has agreed to advance up to A$1,200,000 to Wellteq. The loan will be advanced in tranches not exceeding A$200,000. Amounts advanced under the loan will be due in six months and will bear interest at a rate of 10 per cent per annum.

AHI is a provider of smartphone-based human scanning technology, with a diverse range of data-driven applications in fitness, mHealth, life & health Insurance, and apparel.

Wellteq is a leading global provider of personalized digital health and wellness solutions. 

Wellteq Digital Health Inc (WTEQ) opened trading at C$0.02.


More From The Market Herald

" BetterLife (CSE:BETR) files a comprehensive patent for BETR-001 and other LSD derivatives

BetterLife Pharma (BETR) filed a PCT patent application and a U.S. application for lysergic acid diethylamide (LSD) derivatives, including 2-bromo-LSD.

" Hemostemix (TSXV:HEM) appoints Dr. Ernst von Schwarz to its Scientific Advisory Board

Hemostemix (HEM) has appointed Dr. Ernst von Schwarz, MD, Ph.D., FESC, FACC, FSCAI to its Scientific Advisory Board.

" Mindset Pharma (CSE:MSET) signs intellectual property license with Cybin (NEO:CYBN)

Mindset Pharma (MSET) announced a licensing agreement allowing Cybin (CYBN) to acquire intellectual property rights for a subset of Mindset’s preclinical compounds.